Tau Screening Study in Subjects With Early Symptomatic AD

Summary

This protocol is designed to serve as a pre-screening study for subjects who are potentially eligible for Alzheimer's Disease (AD) therapeutic trials that require tau imaging for inclusion by means of a flortaucipir F18 Positron Emission Tomography (PET) scan.

Timeline

Start

2018-03-08

Primary completion

2018-11-15

Completion

2018-11-15

Drugs

Indications